About Index Trending news
Analyze
Pricing
Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Limited operates as a research-basedpharmaceutical company in Japan.
I work here Suggest edits
More info

Elsewhere

Companies in the same industry

Avro Life Science Avro Life Science SkyQuest Technology Consulting Private Limited SkyQuest Technology Consulting Private Limited Athersys Inc Athersys Inc Aura Biosciences Aura Biosciences Syntimmune Syntimmune Bioquark Inc. Bioquark Inc. Frontida BioPharm, Inc. Frontida BioPharm, Inc. Ritter Pharmaceuticals, Inc. Ritter Pharmaceuticals, Inc. VG Life Sciences VG Life Sciences eXIthera Pharmaceuticals eXIthera Pharmaceuticals

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 11

Portfolio

Portfolio tracker

Acquisitions 1

Apps 4
Add info

Investment profile

Target markets
Medical Health Care Biotechnology Health Diagnostics

Activity

Past year's investments

- Takeda Pharmaceutical participated in 4 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $141,000,000 (averaging $35,250,000 per round).

Latest rounds

- Molecular Templates: Post-IPO equity ($60M)
- PvP Biologics: Venture capital ($35M)
- Avidity NanoMedicines: Venture capital (Series B) ($10M)

Seattle Genetics

Seattle Genetics

Health Care +2
Total funding
$9M in 1 rounds from 1 investors
By Takeda Pharmaceutical
$9M Post-IPO equity in Jan, 2014
Alnylam

Alnylam

Health Care
Total funding
$710M in 2 rounds from 2 investors
By Takeda Pharmaceutical
$10M Venture capital in Mar, 2011
Cortexyme

Cortexyme

Fitness +1
Total funding
$23.6M in 4 rounds from 9 investors
By Takeda Pharmaceutical
$15M Series A in Jan, 2016
Encycle Therapeutics Inc

Encycle Therapeutics Inc

Biotechnology
Total funding
$2.9M in 1 rounds from 4 investors
By Takeda Pharmaceutical
$2.9M Venture Capital in Sep, 2015
Outpost Medicine

Outpost Medicine

Biotechnology +1
Total funding
$41M in 1 rounds from 5 investors
By Takeda Pharmaceutical
$41M Series A in Mar, 2016
Mersana Therapeutics

Mersana Therapeutics

Biotechnology +1
Total funding
$108M in 2 rounds from 7 investors
By Takeda Pharmaceutical
$33M Series C in Jun, 2016
Cerevance

Cerevance

Biotechnology
Total funding
$36M in 1 rounds from 2 investors
By Takeda Pharmaceutical
$36M Series A in Dec, 2016
Avidity NanoMedicines

Avidity NanoMedicines

Manufacturing +2
Total funding
$25.1M in 3 rounds from 13 investors
By Takeda Pharmaceutical
$10M Series B in Jan, 2017
PvP Biologics

PvP Biologics

Pharmaceuticals
Total funding
$35M in 1 rounds from 1 investors
By Takeda Pharmaceutical
$35M Venture Capital in Jan, 2017
Molecular Templates

Molecular Templates

Biotechnology
Total funding
$60M in 1 rounds from 5 investors
By Takeda Pharmaceutical
$60M Post-IPO equity in Aug, 2017

Want to see the complete list?
Go Pro!